Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Acoziborole in g-HAT Seropositive Subjects
NCT05256017Phase 3Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Dec 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of acoziborole in human African trypanosomiasis (HAT), sponsored by Drugs for Neglected Diseases initiative. Started Dec 2021; status: completed.
02
Drugs
acoziborole
03
Conditions
human African trypanosomiasis (HAT)
Beyond the preview
Go deeper on NCT05256017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05256017.